Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors.

Bockhorst JL, Ksseiry I, Toye M, Chipkin SR, Stechenberg BW, Fisher DJ, Allen HF.

Pediatr Infect Dis J. 2003 May;22(5):463-5.

PMID:
12797313
2.

Lipodystrophy syndrome in human immunodeficiency virus-infected children.

Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW.

Pediatr Infect Dis J. 2002 May;21(5):405-10.

PMID:
12150177
4.
5.

Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.

Temple ME, Koranyi KI, Nahata MC.

Ann Pharmacother. 2003 Sep;37(9):1214-8.

PMID:
12921501
6.

Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters.

Maher B, Lloyd J, Wilkins EG, Fraser WD, Back D, Park BK, Pirmohamed M.

Antivir Ther. 2004 Dec;9(6):879-87.

PMID:
15651746
7.

Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.

Verkauskiene R, Dollfus C, Levine M, Faye A, Deghmoun S, Houang M, Chevenne D, Bresson JL, Blanche S, Lévy-Marchal C.

Pediatr Res. 2006 Aug;60(2):225-30.

PMID:
16864709
8.

Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.

Martínez E, Domingo P, Ribera E, Milinkovic A, Arroyo JA, Conget I, Pérez-Cuevas JB, Casamitjana R, de Lazzari E, Bianchi L, Montserrat E, Roca M, Burgos R, Arnaiz JA, Gatell JM.

Antivir Ther. 2003 Oct;8(5):403-10.

PMID:
14640387
9.

Lipodystrophy in pediatric HIV.

Desai N, Mullen P, Mathur M.

Indian J Pediatr. 2008 Apr;75(4):351-4. doi: 10.1007/s12098-008-0037-2. Epub 2008 May 18.

PMID:
18536889
10.

Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.

Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S.

Pediatrics. 2004 Aug;114(2):e235-42.

PMID:
15286262
11.

Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.

Hartman K, Verweel G, de Groot R, Hartwig NG.

Pediatr Infect Dis J. 2006 May;25(5):427-31.

PMID:
16645507
13.

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.

Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, Smith D, Kaldor J, Cooper DA.

HIV Med. 2003 Jul;4(3):293-301.

14.

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.

Lee B, Aurpibul L, Sirisanthana V, Mangklabruks A, Sirisanthana T, Puthanakit T.

HIV Med. 2009 Feb;10(2):72-8. doi: 10.1111/j.1468-1293.2008.00653.x. Epub 2008 Nov 10.

15.

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children.

Larru B, de Mendoza C, Bellón JM, de José MI, Mellado MJ, Soriano V, Muñoz-Fernandez MA, Ramos JT.

BMC Infect Dis. 2007 Jun 10;7:55.

16.

Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.

Moreno-Torres A, Domingo P, Pujol J, Blanco-Vaca F, Arroyo JA, Sambeat MA.

Antivir Ther. 2007;12(2):195-203.

PMID:
17503662
17.

Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age.

Chadwick EG, Rodman JH, Britto P, Powell C, Palumbo P, Luzuriaga K, Hughes M, Abrams EJ, Flynn PM, Borkowsky W, Yogev R; PACTG Protocol 345 Team.

Pediatr Infect Dis J. 2005 Sep;24(9):793-800.

PMID:
16148846
18.

Human immunodeficiency virus type 1: drug resistance in treated and untreated Brazilian children.

Simonetti SR, Schatzmayr HG, Simonetti JP.

Mem Inst Oswaldo Cruz. 2003 Sep;98(6):831-7. Epub 2003 Oct 29.

19.

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.

Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Hervé R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J.

J Clin Densitom. 2005 Fall;8(3):287-92.

PMID:
16055958
20.

Supplemental Content

Support Center